Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 5 | 2026 | 49 | 1.620 |
Why?
|
| Osteosarcoma | 4 | 2026 | 30 | 1.570 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2026 | 4 | 0.970 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2026 | 56 | 0.950 |
Why?
|
| Antineoplastic Agents | 1 | 2026 | 1019 | 0.520 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 95 | 0.520 |
Why?
|
| Interleukins | 1 | 2014 | 40 | 0.430 |
Why?
|
| Camptothecin | 1 | 2013 | 21 | 0.410 |
Why?
|
| Gene Knockdown Techniques | 2 | 2026 | 189 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2026 | 2676 | 0.280 |
Why?
|
| Oxidative Stress | 1 | 2013 | 1003 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2026 | 968 | 0.240 |
Why?
|
| Autophagy | 2 | 2018 | 140 | 0.220 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 80 | 0.140 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 934 | 0.140 |
Why?
|
| Apoptosis | 1 | 2026 | 1568 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2014 | 103 | 0.100 |
Why?
|
| Buthionine Sulfoximine | 1 | 2013 | 13 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 90 | 0.100 |
Why?
|
| Caspases | 1 | 2013 | 148 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2011 | 1 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 134 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 704 | 0.080 |
Why?
|
| Cell Survival | 1 | 2013 | 945 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 79 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1271 | 0.080 |
Why?
|
| Humans | 5 | 2026 | 43102 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 386 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 139 | 0.070 |
Why?
|
| Mice | 3 | 2013 | 6644 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 495 | 0.060 |
Why?
|
| Animals | 3 | 2013 | 16992 | 0.040 |
Why?
|
| Female | 3 | 2018 | 24698 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2011 | 408 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 173 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 374 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 861 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1546 | 0.030 |
Why?
|
| Electroporation | 1 | 2011 | 21 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 244 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 237 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 19 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 84 | 0.020 |
Why?
|
| Child | 1 | 2018 | 3443 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 80 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 157 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 508 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 665 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 436 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5080 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 6081 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 8214 | 0.010 |
Why?
|
| Male | 2 | 2018 | 23409 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1455 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 13872 | 0.010 |
Why?
|